Bio Green Med Solution (BGMS) Equity Average (2016 - 2025)
Historic Equity Average for Bio Green Med Solution (BGMS) over the last 15 years, with Q3 2025 value amounting to $5.4 million.
- Bio Green Med Solution's Equity Average rose 3688965.52% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 3688965.52%. This contributed to the annual value of -$783500.0 for FY2024, which is 10947.06% down from last year.
- Per Bio Green Med Solution's latest filing, its Equity Average stood at $5.4 million for Q3 2025, which was up 3688965.52% from $3.3 million recorded in Q2 2025.
- In the past 5 years, Bio Green Med Solution's Equity Average ranged from a high of $45.6 million in Q2 2021 and a low of -$1.6 million during Q4 2024
- Its 5-year average for Equity Average is $16.7 million, with a median of $8.6 million in 2023.
- As far as peak fluctuations go, Bio Green Med Solution's Equity Average tumbled by 16411.09% in 2024, and later skyrocketed by 3688965.52% in 2025.
- Quarter analysis of 5 years shows Bio Green Med Solution's Equity Average stood at $39.6 million in 2021, then crashed by 51.52% to $19.2 million in 2022, then plummeted by 87.24% to $2.5 million in 2023, then tumbled by 164.11% to -$1.6 million in 2024, then surged by 441.19% to $5.4 million in 2025.
- Its Equity Average was $5.4 million in Q3 2025, compared to $3.3 million in Q2 2025 and $444000.0 in Q1 2025.